4.05
4.05 (-1.64%)
As of Jun 14, 2022
G1 Therapeutics, Inc. [GTHX]
Source:
Company Overview
G1 Therapeutics, Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel small molecule therapeutics for the treatment of patients with cancer.
| Country | United States |
| Headquarters | research triangle park, north carolina |
| Phone Number | (919) 213-9835 |
| Industry | manufacturing |
| CEO | John E. Bailey, Jr |
| Website | www.g1therapeutics.com |